{"id":"mesenchymal-stromal-cells","safety":{"commonSideEffects":[{"rate":null,"effect":"Infusion reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Infection risk"},{"rate":null,"effect":"Immunogenicity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"MSCs secrete anti-inflammatory cytokines (IL-10, TGF-β) and growth factors that suppress pathogenic immune responses and promote tissue repair. They can differentiate into multiple cell types (osteocytes, chondrocytes, adipocytes) and home to damaged tissues, facilitating regeneration and reducing inflammation in autoimmune and degenerative conditions.","oneSentence":"Mesenchymal stromal cells (MSCs) are bone marrow-derived multipotent cells that exert immunomodulatory and tissue-regenerative effects through paracrine signaling and direct cell-cell interactions.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:54:35.990Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Graft-versus-host disease (GVHD)"},{"name":"Acute myocardial infarction"},{"name":"Osteoarthritis"},{"name":"Systemic lupus erythematosus"}]},"trialDetails":[{"nctId":"NCT06321198","phase":"NA","title":"A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2024-02-10","conditions":"Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)","enrollment":12},{"nctId":"NCT06969807","phase":"PHASE2","title":"Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2025-06-09","conditions":"Diabetic Kidney Disease (DKD)","enrollment":120},{"nctId":"NCT06798623","phase":"PHASE1","title":"Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-24","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":15},{"nctId":"NCT07487467","phase":"NA","title":"Autologous SVF Therapy for Type 2 Diabetes","status":"RECRUITING","sponsor":"Kaiser Clinic and Hospital","startDate":"2025-01-20","conditions":"Diabetes Mellitus, Type 2","enrollment":10},{"nctId":"NCT07339111","phase":"PHASE3","title":"Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis","status":"RECRUITING","sponsor":"Medipost, Inc.","startDate":"2026-03-11","conditions":"Knee Cartilage Defects","enrollment":300},{"nctId":"NCT04615429","phase":"PHASE2","title":"Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS","status":"COMPLETED","sponsor":"Cristina Avendaño Solá","startDate":"2020-09-15","conditions":"Acute Respiratory Distress Syndrome, COVID-19 Pneumonia","enrollment":20},{"nctId":"NCT03268603","phase":"PHASE2","title":"Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-10-10","conditions":"ALS, Amyotrophic Lateral Sclerosis","enrollment":75},{"nctId":"NCT07452822","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Topcel-KH Pharmaceutical Co., Ltd.","startDate":"2026-02-20","conditions":"Arteriovenous Fistula Stenosis","enrollment":54},{"nctId":"NCT07431645","phase":"PHASE1","title":"Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-04-01","conditions":"Radiation-Induced Xerostomia, Head and Neck Cancer","enrollment":10},{"nctId":"NCT07439848","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2023-12-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":15},{"nctId":"NCT07441226","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients","status":"RECRUITING","sponsor":"RSUP Persahabatan","startDate":"2025-08-08","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":20},{"nctId":"NCT05008588","phase":"PHASE1, PHASE2","title":"Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-05-30","conditions":"Ischemic Stroke","enrollment":15},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT04314661","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2020-08-03","conditions":"Osteoarthritis, Knee","enrollment":31},{"nctId":"NCT06040957","phase":"NA","title":"Bone Marrow Versus Adipose Tissue as a Cell Source for Infiltrative Treatment of Knee Osteoarthritis","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2024-01-08","conditions":"Knee Osteoarthritis","enrollment":204},{"nctId":"NCT07413549","phase":"PHASE1, PHASE2","title":"Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis","status":"RECRUITING","sponsor":"Beijing Tuohua Weiye Biotechnology Co., Ltd.","startDate":"2025-02-25","conditions":"Decompensated Hepatitis B Cirrhosis","enrollment":76},{"nctId":"NCT07413978","phase":"PHASE1, PHASE2","title":"A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome","status":"RECRUITING","sponsor":"Changchun Tuohua Pharmaceutical Co., Ltd.","startDate":"2025-04-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":36},{"nctId":"NCT04328714","phase":"PHASE1","title":"Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease","status":"TERMINATED","sponsor":"Edwin Horwitz","startDate":"2021-12-02","conditions":"Acute Leukemia, Myelodysplastic Syndromes","enrollment":4},{"nctId":"NCT03504241","phase":"PHASE1","title":"Tolerance by Engaging Antigen During Cellular Homeostasis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-07-30","conditions":"Kidney Transplantation, Renal Transplantation, Renal Transplant Recipient","enrollment":8},{"nctId":"NCT05697718","phase":"PHASE1","title":"Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke","status":"COMPLETED","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2023-04-10","conditions":"Ischemic Stroke","enrollment":18},{"nctId":"NCT07299123","phase":"PHASE1, PHASE2","title":"Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese PLA General Hospital","startDate":"2023-08-01","conditions":"Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia","enrollment":40},{"nctId":"NCT06392711","phase":"PHASE1","title":"Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-10-04","conditions":"Xerostomia, Graft-versus-host-disease, Sjogren's Disease","enrollment":36},{"nctId":"NCT07396155","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-07-01","conditions":"Diabetic Nephropathy Type 2","enrollment":10},{"nctId":"NCT05820711","phase":"PHASE1","title":"Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2023-07-17","conditions":"Head and Neck Cancer, Xerostomia","enrollment":23},{"nctId":"NCT07295067","phase":"PHASE1","title":"Extracellular Vesicles for the Treatment of Syringomyelia","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-23","conditions":"Syringomyelia","enrollment":18},{"nctId":"NCT07304440","phase":"PHASE1, PHASE2","title":"Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study","status":"RECRUITING","sponsor":"Adia Med of Winter Park LLC","startDate":"2026-01-12","conditions":"Autism Spectrum Disorder, Autism, ASD","enrollment":100},{"nctId":"NCT06840275","phase":"PHASE2","title":"ASCs in Recently Diagnosed Non-ischemic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Cell to Cure ApS","startDate":"2026-03-01","conditions":"Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure","enrollment":90},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT05095532","phase":"PHASE1","title":"Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2021-12-01","conditions":"Chronic Pancreatitis, Mesenchymal Stem Cells","enrollment":42},{"nctId":"NCT05465096","phase":"NA","title":"Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.","status":"COMPLETED","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2022-10-24","conditions":"Hip Osteoarthritis, Hip Disease","enrollment":30},{"nctId":"NCT04356287","phase":"PHASE1, PHASE2","title":"Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis","status":"RECRUITING","sponsor":"Marie Hudson, MD","startDate":"2023-01-05","conditions":"Sclerosis, Systemic, Mesenchymal Stem Cells","enrollment":18},{"nctId":"NCT06919081","phase":"PHASE2","title":"Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-08-01","conditions":"Persistent Corneal Epithelial Defect, Corneal Epithelial Disorders","enrollment":24},{"nctId":"NCT05204329","phase":"EARLY_PHASE1","title":"Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2024-01-24","conditions":"Mesenchymal Stromal Cells, Cornea, Corneal Defect","enrollment":9},{"nctId":"NCT03325322","phase":"PHASE2","title":"Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease","status":"SUSPENDED","sponsor":"Mayo Clinic","startDate":"2018-01-02","conditions":"Chronic Kidney Diseases, Diabetes Mellitus, Diabetic Nephropathies","enrollment":30},{"nctId":"NCT06752577","phase":"","title":"Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-12-22","conditions":"Chronic Kidney Diseases, Kidney Transplant","enrollment":75},{"nctId":"NCT07371624","phase":"PHASE1, PHASE2","title":"A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke.","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2025-12-31","conditions":"Acute Ischemic Stroke","enrollment":54},{"nctId":"NCT06075706","phase":"PHASE2","title":"Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"medac GmbH","startDate":"2023-11-13","conditions":"Steroid-refractory Acute Graft-versus-host Disease","enrollment":48},{"nctId":"NCT04290182","phase":"PHASE1, PHASE2","title":"A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring","status":"COMPLETED","sponsor":"Karolinska University Hospital","startDate":"2021-03-01","conditions":"Hoarseness, Dysphonia, Aphonia","enrollment":9},{"nctId":"NCT05331872","phase":"PHASE1","title":"Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-01-01","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT06981741","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint","status":"RECRUITING","sponsor":"BIONCaRT GmbH","startDate":"2025-11-10","conditions":"Cartilage Damage","enrollment":55},{"nctId":"NCT07265349","phase":"PHASE1, PHASE2","title":"A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2025-12-26","conditions":"Coronary Artery Bypass Grafting (CABG), Chronic Heart Failure, Chronic Ischemic Cardiomyopathy","enrollment":51},{"nctId":"NCT07326033","phase":"PHASE2","title":"Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2026-01","conditions":"Systemic Scleroderma","enrollment":50},{"nctId":"NCT02962661","phase":"PHASE1","title":"Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-18","conditions":"Cardiomyopathy, Heart Failure, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":72},{"nctId":"NCT07319533","phase":"PHASE2","title":"Clinical Trial Investigating the Effect of Exosomes as a Complementary Treatment in Severe to Moderate Erectile Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Labbafinejad Medical Center","startDate":"2026-01","conditions":"Erectile Dysfunction, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus, Erectile Dysfunction Due to Arterial Disease","enrollment":70},{"nctId":"NCT06592703","phase":"PHASE1","title":"Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis","status":"RECRUITING","sponsor":"Rennes University Hospital","startDate":"2025-03-06","conditions":"Multiple Sclerosis","enrollment":10},{"nctId":"NCT07313020","phase":"EARLY_PHASE1","title":"Handheld MPI Imaging to Track Stem Cells in Osteoarthritis","status":"ENROLLING_BY_INVITATION","sponsor":"Soochow University","startDate":"2025-12-16","conditions":"Knee Arthritis Osteoarthritis","enrollment":10},{"nctId":"NCT04452097","phase":"PHASE1, PHASE2","title":"Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS","status":"WITHDRAWN","sponsor":"Baylx Inc.","startDate":"2026-06-01","conditions":"COVID-19, ARDS, Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT07305623","phase":"PHASE3","title":"Safety and Efficacy of Bone Bioengineering Kit With Stem Cells for Alveolar Cleft Repair","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Tecnologia do Paraná","startDate":"2026-07","conditions":"Cleft Lip Palate","enrollment":205},{"nctId":"NCT05595681","phase":"PHASE1","title":"Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.","status":"TERMINATED","sponsor":"Cell to Cure ApS","startDate":"2022-12-15","conditions":"Diabetic Foot Ulcer, Mesenchymal Stromal Cells","enrollment":21},{"nctId":"NCT06328712","phase":"PHASE1","title":"Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A","status":"COMPLETED","sponsor":"ENCell","startDate":"2024-05-30","conditions":"Charcot-Marie-Tooth Disease Type 1A","enrollment":6},{"nctId":"NCT05705024","phase":"PHASE2","title":"Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2023-09-29","conditions":"Corneal Ulcer","enrollment":38},{"nctId":"NCT05838092","phase":"PHASE3","title":"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)","status":"ACTIVE_NOT_RECRUITING","sponsor":"RHEACELL GmbH & Co. KG","startDate":"2023-10-18","conditions":"Epidermolysis Bullosa","enrollment":9},{"nctId":"NCT05464381","phase":"PHASE3","title":"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)","status":"ACTIVE_NOT_RECRUITING","sponsor":"RHEACELL GmbH & Co. KG","startDate":"2023-06-13","conditions":"Epidermolysis Bullosa","enrollment":91},{"nctId":"NCT06589271","phase":"PHASE1","title":"SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Lumbar Disc Degeneration","enrollment":20},{"nctId":"NCT03818854","phase":"PHASE2","title":"Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Michael A. Matthay","startDate":"2019-11-26","conditions":"Respiratory Distress Syndrome, Adult","enrollment":120},{"nctId":"NCT06503471","phase":"PHASE1","title":"SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Infertility, Female","enrollment":24},{"nctId":"NCT03816852","phase":"PHASE2","title":"The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2018-10-01","conditions":"Premature Ovarian Failure","enrollment":12},{"nctId":"NCT04971161","phase":"PHASE2","title":"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)","status":"COMPLETED","sponsor":"RHEACELL GmbH & Co. KG","startDate":"2021-08-18","conditions":"Skin Ulcer Venous Stasis Chronic","enrollment":159},{"nctId":"NCT03383081","phase":"PHASE2","title":"The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis","status":"RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2018-10-01","conditions":"Osteoarthritis, Knee","enrollment":60},{"nctId":"NCT04104412","phase":"PHASE1","title":"The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain","status":"RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2019-08-15","conditions":"Lumbar Discogenic Pain","enrollment":242},{"nctId":"NCT03608631","phase":"PHASE1, PHASE2","title":"iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-01-27","conditions":"KRAS NP_004976.2:p.G12D, Metastatic Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma","enrollment":28},{"nctId":"NCT03826433","phase":"PHASE1","title":"hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis","status":"RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2018-10-01","conditions":"Hepatitis B","enrollment":20},{"nctId":"NCT07232563","phase":"PHASE1","title":"Exploratory Study of Intranasal Administration of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2025-12-01","conditions":"Ischemic Stroke","enrollment":9},{"nctId":"NCT07232147","phase":"PHASE1","title":"Clinical Research on Stem Cell Therapy for Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.","startDate":"2025-12-01","conditions":"Parkinson Disease (PD), Neurodegenerative Diseases, Movement Disorders","enrollment":20},{"nctId":"NCT03608579","phase":"PHASE1","title":"Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-11-05","conditions":"Osteoarthritis, Hip","enrollment":24},{"nctId":"NCT04744116","phase":"EARLY_PHASE1","title":"Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-17","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Steroid Refractory Graft Versus Host Disease","enrollment":24},{"nctId":"NCT04456439","phase":"","title":"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)","status":"NO_LONGER_AVAILABLE","sponsor":"Mesoblast International Sàrl","startDate":"","conditions":"Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)","enrollment":""},{"nctId":"NCT05559801","phase":"PHASE1, PHASE2","title":"Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III","enrollment":12},{"nctId":"NCT05789394","phase":"PHASE1","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-06-16","conditions":"Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Astrocytoma, Grade IV","enrollment":20},{"nctId":"NCT03909139","phase":"","title":"Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2019-09-06","conditions":"Acetabular Labrum Tear, Femoro Acetabular Impingement, Chondral Defect","enrollment":400},{"nctId":"NCT05456243","phase":"PHASE1","title":"Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-01-30","conditions":"Kidney Transplant","enrollment":12},{"nctId":"NCT01071577","phase":"","title":"Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products","status":"TERMINATED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2010-03-17","conditions":"Bone Marrow Stromal Cells","enrollment":65},{"nctId":"NCT06489028","phase":"PHASE3","title":"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)","status":"ACTIVE_NOT_RECRUITING","sponsor":"RHEACELL GmbH & Co. KG","startDate":"2024-12-26","conditions":"Venous Leg Ulcer","enrollment":250},{"nctId":"NCT02838069","phase":"PHASE2","title":"A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2016-09-20","conditions":"Osteoarthritis","enrollment":100},{"nctId":"NCT07084012","phase":"PHASE2","title":"A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS","status":"RECRUITING","sponsor":"Shenzhen Wingor Biotechnology Co., Ltd.","startDate":"2025-08-27","conditions":"Acute Ischemic Stroke AIS","enrollment":60},{"nctId":"NCT07197606","phase":"PHASE2","title":"Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2025-10-01","conditions":"Ischemic Stroke","enrollment":86},{"nctId":"NCT02685098","phase":"PHASE1","title":"A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-01-23","conditions":"Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease","enrollment":81},{"nctId":"NCT07183761","phase":"PHASE2","title":"A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects With Moderate to Severe Diabetic Peripheral Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Min Long","startDate":"2025-10-01","conditions":"Diabetic Peripheral Neuropathy (DPN)","enrollment":140},{"nctId":"NCT06737380","phase":"PHASE1","title":"UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients","status":"RECRUITING","sponsor":"LiveKidney.Bio","startDate":"2025-01-07","conditions":"SLE, Lupus, Systemic Lupus Erthematosus","enrollment":10},{"nctId":"NCT06464588","phase":"PHASE1","title":"A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-07-14","conditions":"Dilated Cardiomyopathy","enrollment":36},{"nctId":"NCT03211793","phase":"PHASE1, PHASE2","title":"Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2021-10-06","conditions":"Systemic Sclerosis, Digital Ulcer","enrollment":20},{"nctId":"NCT04126603","phase":"PHASE4","title":"Impact of Semaglutide on CD34+ EPC and Fat Derived MSC","status":"COMPLETED","sponsor":"Sabyasachi Sen","startDate":"2019-08-01","conditions":"Diabetes Mellitus, Type 2","enrollment":10},{"nctId":"NCT05854615","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Buerger's Disease","enrollment":3},{"nctId":"NCT04869397","phase":"PHASE2","title":"Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2021-06-14","conditions":"Covid19","enrollment":19},{"nctId":"NCT03042143","phase":"PHASE1, PHASE2","title":"Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Belfast Health and Social Care Trust","startDate":"2019-01-07","conditions":"Acute Respiratory Distress Syndrome","enrollment":129},{"nctId":"NCT06954740","phase":"PHASE2","title":"Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2025-06-10","conditions":"Acute Kidney Injury","enrollment":50},{"nctId":"NCT06167473","phase":"NA","title":"Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD","status":"ACTIVE_NOT_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2023-11-28","conditions":"End-stage Liver Diseases","enrollment":22},{"nctId":"NCT07144241","phase":"PHASE2","title":"Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients","status":"NOT_YET_RECRUITING","sponsor":"Indonesia University","startDate":"2025-09-01","conditions":"Type 2 Diabetes Mellitus","enrollment":50},{"nctId":"NCT06984497","phase":"NA","title":"Human Umbilical Cord-mesenchymal Stem Cells Via Different Transplantation Routes in ESLD","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-09","conditions":"End-Stage Liver Diseases","enrollment":32},{"nctId":"NCT07137559","phase":"","title":"CELZ-201-DDT for the Treatment of Chronic Lower Back Pain","status":"AVAILABLE","sponsor":"Creative Medical Technology Holdings Inc","startDate":"","conditions":"Chronic Back Pain, Degenerative Disc Disease Lumbar","enrollment":""},{"nctId":"NCT04919135","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-10-19","conditions":"Frailty","enrollment":158},{"nctId":"NCT03840343","phase":"PHASE1","title":"Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2019-10-23","conditions":"Diabetic Kidney Disease, Diabetic Nephropathies, Diabetes Mellitus, Type 2","enrollment":2},{"nctId":"NCT06551649","phase":"NA","title":"Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-01-17","conditions":"Amyotrophic Lateral Sclerosis, Multiple Sclerosis","enrollment":60},{"nctId":"NCT04629833","phase":"PHASE3","title":"Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy","status":"RECRUITING","sponsor":"medac GmbH","startDate":"2021-08-16","conditions":"Steroid-refractory Acute Graft-versus-host Disease","enrollment":210},{"nctId":"NCT06684379","phase":"PHASE1, PHASE2","title":"Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)","status":"RECRUITING","sponsor":"PEACHES BIOTECH","startDate":"2024-10-02","conditions":"SARS-CoV-2, Influenza, Human, Respiratory Syncytial Virus Infections","enrollment":50},{"nctId":"NCT04711200","phase":"PHASE1, PHASE2","title":"LYell SYndrome MEsenchymal Stromal Cells Treatment","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-04-15","conditions":"Epidermal Necrolysis, Lyell Syndrome, Toxic Epidermal Necrolysis","enrollment":15},{"nctId":"NCT04865107","phase":"PHASE2","title":"Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2021-04-27","conditions":"Covid19, Acute Respiratory Distress Syndrome","enrollment":22},{"nctId":"NCT06539273","phase":"PHASE3","title":"Exosome Treatment in Androgenetic Alopecia","status":"COMPLETED","sponsor":"Yeditepe University Hospital","startDate":"2024-01-01","conditions":"Androgenetic Alopecia, Exosomes","enrollment":30},{"nctId":"NCT04255147","phase":"PHASE1","title":"Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2022-10-17","conditions":"Bronchopulmonary Dysplasia","enrollment":9},{"nctId":"NCT07058025","phase":"PHASE2","title":"Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2025-10-01","conditions":"Bronchopulmonary Dysplasia (BPD), ELGAN (22-28SA)","enrollment":168}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11683,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MSC","bone marrow derived mesenchymal stromal cells","TC-MSC","Allogeneic Cellular Therapy (NEPHSTROM ORBCEL-M)","Bone marrow derived mesenchymal stromal cells"],"phase":"marketed","status":"active","brandName":"Mesenchymal stromal cells","genericName":"Mesenchymal stromal cells","companyName":"National Research Center for Hematology, Russia","companyId":"national-research-center-for-hematology-russia","modality":"Biologic","firstApprovalDate":"","aiSummary":"Mesenchymal stromal cells (MSCs) are multipotent bone marrow-derived cells that exert immunomodulatory and tissue-regenerative effects through paracrine signaling and direct cell-cell interactions. Used for Graft-versus-host disease (GVHD), Acute myocardial infarction, Tissue repair and regeneration.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":5,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}